(Q36876023)

16 August 2017

1 reference

title

Homocysteine lowering and cardiovascular disease risk: lost in translation (English)

1 reference

16 August 2017

cardiovascular disease

1 reference

Jeremy Marcus

1

1 reference

16 August 2017

Mark J Sarnak

series ordinal

2

1 reference

16 August 2017

Vandana Menon

series ordinal

3

1 reference

16 August 2017

language of work or name

1 reference

1 July 2007

1 reference

The Canadian Journal of Cardiology

16 August 2017

1 reference

16 August 2017

23

1 reference

16 August 2017

9

1 reference

16 August 2017

707-710

1 reference

Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Homocysteine lowering and cardiovascular events after acute myocardial infarction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Homocysteine lowering with folic acid and B vitamins in vascular disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Relationship between homocysteine and mortality in chronic kidney disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Improvement in stroke mortality in Canada and the United States, 1990 to 2002.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Homocysteine trials--clear outcomes for complex reasons

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2651913

Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study

4 September 2018

1 reference

12 December 2020

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Testing the homocysteine hypothesis in end-stage renal disease: Problems and a possible solution

1 reference

12 December 2020

Trials that matter: should we routinely measure homocysteine levels and "treat" mild hyperhomocysteinemia?

1 reference

12 December 2020

Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial

1 reference

12 December 2020

A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)

1 reference

12 December 2020

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

12 December 2020

Homocysteine and atherothrombosis

1 reference

12 December 2020

10.1016/S0828-282X(07)70814-0

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

1 reference